2007Emerging infectious diseasesOpen access

Ertapenem Resistance ofEscherichia coli

Marie-Frédérique Lartigue, Laurent Poirel, Claire Poyart, Hélène Réglier‐Poupet, Patrice Nordmann

Open full text 96 citations

Abstract

An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.

Open-access reader

About this research paper

What this paper is about

An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.

Why it matters

OpenAlex reports 96 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

An ertapenem-resistant Escherichia coli isolate was recovered from peritoneal fluid in a patient who had been treated with imipenem/cilastatin for 10 days. Ertapenem resistance may be explained by a defect in the outer membrane protein and production of extended-spectrum beta-lactamase CTX-M-2.

Key concepts: Ertapenem, Escherichia coli, Microbiology, Imipenem, Bacterial outer membrane, Meropenem, Enterobacteriaceae, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Ertapenem Resistance ofEscherichia coli — Research Paper | ScholarLens